Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Redner

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Advances in Biological Regulation|June 17, 2014
STAT transcription factors in normal and cancer stem cellsKathleen A Dorritie, Robert L Redner, Daniel E Johnson
Molecular Cancer Therapeutics|December 11, 2007
Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiationMichelle B Miranda, Robert L Redner, Daniel E Johnson
Leukemia & Lymphoma|January 20, 2018
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acidSamir Mazharuddin, Anuja Chattopadhyay, Moshe Y Levy, et al.
Molecular Cancer Research : MCR|July 19, 2014
Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADDAnuja Chattopadhyay, Brian L Hood, Thomas P Conrads, et al.
Leukemia Research|November 5, 2013
Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockadeElizabeth A Rush, Sheri L Pollock, Irina Abecassis, et al.
Leukemia Research|March 1, 2006
The NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PMLElizabeth A Rush, Kimberly W Schlesinger, Simon C Watkins, et al.
Leukemia & Lymphoma|April 11, 2015
Outcomes of acute myeloid leukemia with t(15;17) not associated with acute promyelocytic leukemiaAmy Soni, Miroslav Djokic, Jing-Zhou Hou, et al.
Leukemia & Lymphoma|January 13, 2016
The leukemic oncoprotein NPM1-RARA inhibits TP53 activityErin M Swaney, Anuja Chattopadhyay, Irina Abecassis, et al.
Annals of Hematology|September 22, 2010
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapyMichael Boyiadzis, Robert L Redner, Anastasios Raptis, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2008
Effect of antacid on imatinib absorptionBrian A Sparano, Merrill J Egorin, Robert A Parise, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Advances in Biological Regulation|June 17, 2014
STAT transcription factors in normal and cancer stem cellsKathleen A Dorritie, Robert L Redner, Daniel E Johnson
Molecular Cancer Therapeutics|December 11, 2007
Inhibition of Src family kinases enhances retinoic acid induced gene expression and myeloid differentiationMichelle B Miranda, Robert L Redner, Daniel E Johnson
Leukemia & Lymphoma|January 20, 2018
IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acidSamir Mazharuddin, Anuja Chattopadhyay, Moshe Y Levy, et al.
Molecular Cancer Research : MCR|July 19, 2014
Extrinsic apoptosis is impeded by direct binding of the APL fusion protein NPM-RAR to TRADDAnuja Chattopadhyay, Brian L Hood, Thomas P Conrads, et al.
Leukemia Research|November 5, 2013
Interaction with RXR is necessary for NPM-RAR-induced myeloid differentiation blockadeElizabeth A Rush, Sheri L Pollock, Irina Abecassis, et al.
Leukemia Research|March 1, 2006
The NPM-RAR fusion protein associated with the t(5;17) variant of APL does not interact with PMLElizabeth A Rush, Kimberly W Schlesinger, Simon C Watkins, et al.
Leukemia & Lymphoma|April 11, 2015
Outcomes of acute myeloid leukemia with t(15;17) not associated with acute promyelocytic leukemiaAmy Soni, Miroslav Djokic, Jing-Zhou Hou, et al.
Leukemia & Lymphoma|January 13, 2016
The leukemic oncoprotein NPM1-RARA inhibits TP53 activityErin M Swaney, Anuja Chattopadhyay, Irina Abecassis, et al.
Annals of Hematology|September 22, 2010
Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapyMichael Boyiadzis, Robert L Redner, Anastasios Raptis, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2008
Effect of antacid on imatinib absorptionBrian A Sparano, Merrill J Egorin, Robert A Parise, et al.
Pageof 5